100% of treated patients achieved 20/30 or better Best Corrected Distance Visual Acuity (BCDVA) at 24 months ALISO VIEJO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a late-stage ...
On March 9, 2026, SpyGlass Pharma announced positive 12-month results from its phase 1/2 trial of the Bimatoprost Drug ...
Dr Jonathan Ingram has become known as the ‘father of BIM’ for designing and writing the first building information modelling (BIM) systems, including Sonata and REfLEX. He also taught the first BIM ...
97% of patients who received the BIM-IOL System off all topical IOP-lowering therapy at 12-months 100% of BIM-IOL System patients achieved 20/32 or better BCDVA and a mean BCDVA equivalent to 20/20 ...
First-in-Human(FIH)Trialat36Months: PhaseI/IITrialat3Months: 37% and 36% reduction in mean IOP with 98% and 96% of patients off topical IOP-lowering drops in 78 mcg and 39 mcg dose groups, ...
42% reduction in mean intraocular pressure (IOP) compared to baseline (p 100% of patients were off all topical IOP-lowering medications at 24 months 100% of treated patients achieved 20/30 or better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results